Elikem – for potency | Buy in Ukraine with delivery

What is ELIKEM?

The drug ELIKEM is a modern, highly effective medicinal product that is widely used in therapeutic practice for the comprehensive treatment and prevention of diseases of the cardiovascular system. This pharmacological product belongs to the group of antiplatelet and antithrombotic medications, which play a key role in preventing the formation of dangerous blood clots. The pharmaceutical manufacturer ELIKEM developed this drug in compliance with the strictest international quality standards, which guarantees a high safety profile and a predictable therapeutic effect. The medical product is available in the form of film-coated tablets that protect the active components from the aggressive action of gastric juice and ensure their gradual release in the intestine.

The main purpose of the medicinal product ELIKEM is to optimize the rheological properties of blood and reduce the risk of thrombotic complications in patients at risk of ischemic lesions. The pharmacological group of this drug includes agents affecting the blood coagulation system and the functional activity of platelets, inhibiting their excessive aggregation. Thanks to the unique formula developed by the pharmaceutical company ELIKEM, the agent provides a long-lasting and stable action, allowing to minimize the frequency of administration and improve patient compliance. The correct use of this medicine under medical supervision helps to significantly reduce the rate of hospitalizations associated with acute coronary syndromes and cerebrovascular disorders.

Systematic use of the medication ELIKEM is prescribed by doctors after a thorough cardiological or neurological examination of the patient to assess the state of the vascular bed. The manufacturer ELIKEM pays special attention to the purity of raw materials and the accuracy of active ingredient dosage, making this agent sought after among relevant specialists. The tablet dosage form provides ease of use in both inpatient and outpatient settings over a long period. Before starting the course, a consultation with a doctor is mandatory, as self-treatment with antiplatelet agents can pose a health threat.

What is ELIKEM prescribed for?

The therapeutic spectrum of application of the medication ELIKEM covers several main pathological conditions associated with a high risk of intravascular thrombus formation. The primary indication is secondary prevention of atherothrombotic events in adult patients who have previously suffered a myocardial infarction, ischemic stroke, or have established peripheral arterial disease. The drug effectively suppresses the pathological clumping of blood cells, preventing re-occlusion of vital vessels and reducing overall mortality rates from cardiovascular catastrophes. Regular intake of this agent makes it possible to maintain necessary blood fluidity in patients with chronic ischemic heart disease.

In addition, the medicinal product ELIKEM is widely used as part of the comprehensive treatment of acute coronary syndrome, including unstable angina and non-ST-segment elevation myocardial infarction. In such clinical situations, the medication is combined with other antithrombotic drugs to achieve a rapid and pronounced protective effect. The drug is also indicated for patients after percutaneous coronary intervention or stenting, where it prevents thrombosis of the implanted endoprosthesis. Timely initiation of therapy helps maintain the patency of coronary vessels and minimize the area of heart muscle damage.

Another important area of application for this medical agent is the prevention of thromboembolic complications in atrial fibrillation in cases where anticoagulant therapy cannot be prescribed for certain reasons. Patients with cardiac arrhythmias have an increased risk of blood clot formation in the heart cavities with their subsequent migration into cerebral vessels. Prescribing ELIKEM allows building a reliable barrier against ischemic damage to brain tissues and improving the long-term prognosis of life. The decision on the appropriateness of using the medicine in each specific case is made exclusively by a qualified specialist.

Composition and active components of ELIKEM

The main active substance of the medication ELIKEM is a highly purified antiplatelet component that specifically and irreversibly binds to purinergic receptors on the platelet surface. The mechanism of action of this substance consists in the selective inhibition of adenosine diphosphate (ADP) binding to its P2Y12 receptors and the subsequent ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. Due to this process, platelets lose the ability to aggregate with each other and adhere to the damaged endothelial vascular wall. Such targeted suppression of platelet function persists for their entire lifespan, which is approximately seven to ten days.

In addition to the main pharmaceutical ingredient, the composition of the ELIKEM tablet includes carefully selected excipients that ensure structural integrity, stability, and proper absorption of the medication. These include microcrystalline cellulose, lactose monohydrate, magnesium stearate, colloidal anhydrous silica, and special polymers for forming the protective coating. The film coating of the tablet prevents irritation of the gastric mucosa and regulates the dissolution rate of the dosage form in the digestive tract. All excipients are pharmaceutically inert and comply with strict pharmacopoeial quality requirements.

ELIKEM Dosage

The standard dosage regimen of ELIKEM for adult patients involves taking one tablet at a dose of 75 mg once daily at the same time. In the treatment of acute coronary syndrome, therapy usually begins with a single loading dose, which may be 300 mg, followed by a switch to a maintenance dose of 75 mg per day. The duration of the treatment course is determined by the doctor individually and can vary from several months to a lifelong step-by-step administration for secondary prevention. All changes in dosage must be carried out exclusively under medical supervision with periodic monitoring of coagulogram parameters.

For elderly patients, as well as persons with moderate impairment of renal or hepatic function, special dose adjustment of ELIKEM is usually not required; however, increased caution is necessary. In severe renal or hepatic impairment, the use of this agent may be restricted due to the increased risk of hemorrhagic complications. The doctor may adjust the administration scheme depending on concomitant pathology and the simultaneous use of other medications. Exceeding or reducing the recommended dose on one's own is strictly prohibited, as this may lead to decreased efficacy or the development of bleeding.

How to take ELIKEM correctly?

ELIKEM tablets should be taken whole, without chewing, crushing, or breaking them, swallowed with a sufficient amount of clean drinking water at room temperature. At the same time, taking the medicine is not tied to food intake: the drug can be consumed before, during, or after meals, as food does not significantly affect the absorption level of the active substance. However, to form a stable habit and maintain a constant concentration of the active ingredient in blood plasma, it is recommended to consume the medication daily at the same hours. This minimizes fluctuations in the antiplatelet effect throughout the day.

If the patient misses a regular dose of ELIKEM, it should be taken as soon as it is noticed, provided that less than 12 hours have passed since the scheduled time. If the delay exceeds 12 hours, the missed tablet should not be taken, and the next one should be consumed at the usual scheduled time. Taking a double dose of the medication to make up for a missed one is prohibited, as this sharply increases the risk of developing undesirable hemorrhagic events. Before undergoing any planned surgical interventions or dental procedures, it is necessary to inform the doctor in advance about taking this antiplatelet agent.

ELIKEM Side Effects

Like any active pharmaceutical agent, ELIKEM tablets can cause side effects, although they do not occur in every patient. The most common adverse effects are hemorrhagic events, such as bruising, subcutaneous hematomas, nosebleeds, as well as gastrointestinal bleeding of varying severity. From the digestive tract, patients may sometimes experience abdominal pain, dyspepsia, nausea, diarrhea, or constipation. It is important to remember the possibility of an individual reaction of the body to the active or auxiliary components of the medication.

Uncommon and rare side effects when taking ELIKEM include pronounced thrombocytopenia, leukopenia, dizziness, headache, paresthesia, and gastric or duodenal ulceration. In isolated cases, severe allergic reactions may develop, including urticaria, angioedema, or bronchospasm. If symptoms such as black stool, vomiting with blood, sudden dizziness, or the appearance of multiple pinpoint hemorrhages on the skin occur, you should immediately stop taking the medicine and seek emergency medical care.

ELIKEM Contraindications

An absolute contraindication to the use of the drug ELIKEM is individual hypersensitivity or allergy to the active substance or any of the auxiliary compounds. The medication is strictly forbidden to be prescribed to patients with acute pathological bleeding, such as active peptic ulcer disease or intracranial hemorrhage. Severe hepatic impairment is also a contraindication, as it can lead to impaired synthesis of blood clotting factors. The use of the drug in children and adolescents under 18 years of age is prohibited due to the lack of sufficient safety data.

Relative contraindications for prescribing ELIKEM require a careful assessment of the benefit-risk ratio by a physician. This group includes patients with an increased tendency to bleed resulting from trauma, recent surgical procedures, or pathological conditions. During pregnancy and lactation, taking this medication is not recommended, except in cases of extreme clinical necessity under strict medical supervision. Before starting the course, be sure to consult with a doctor to rule out hidden contraindications and develop a safe therapy plan.

Interaction of ELIKEM with other drugs and alcohol

Concomitant use of the medication ELIKEM with other medicinal products requires increased medical monitoring due to the risk of pharmacodynamic interaction. Simultaneous administration with oral anticoagulants, nonsteroidal anti-inflammatory drugs (NSAIDs), heparin, or other antiplatelet agents significantly increases the risk of bleeding at various sites. Selective serotonin reuptake inhibitors may also enhance hemorrhagic risks when taken together. The patient must inform the doctor about all pharmaceutical products taken on a regular or periodic basis.

The consumption of alcoholic beverages during maintenance therapy with ELIKEM is strictly contraindicated. Ethanol has an irritating effect on the mucosa of the gastrointestinal tract and suppresses platelet function, which, in combination with the medicine, significantly increases the risk of gastric bleeding. Regarding driving or operating other complex mechanisms, the medication usually does not affect the speed of psychomotor reactions; however, in case of dizziness or increased fatigue, one should temporarily refrain from such activities.

Where to buy ELIKEM in Ukraine

You can purchase the high-quality drug ELIKEM in Ukraine at most licensed pharmacy chains or order it through official pharmaceutical web services with the option of delivery to the nearest pharmacy outlet. Since this medication belongs to the prescription category, its dispensing is carried out exclusively upon presentation of a properly issued prescription from the attending physician. It is necessary to store this pharmaceutical product in its original packaging in a dry place, protected from light and out of reach of children, at a temperature not exceeding 25 degrees Celsius.